311 related articles for article (PubMed ID: 33772011)
21. Sulf1 and Sulf2 Differentially Modulate Heparan Sulfate Proteoglycan Sulfation during Postnatal Cerebellum Development: Evidence for Neuroprotective and Neurite Outgrowth Promoting Functions.
Kalus I; Rohn S; Puvirajesinghe TM; Guimond SE; Eyckerman-Kölln PJ; Ten Dam G; van Kuppevelt TH; Turnbull JE; Dierks T
PLoS One; 2015; 10(10):e0139853. PubMed ID: 26448642
[TBL] [Abstract][Full Text] [Related]
22. The SULFs, extracellular sulfatases for heparan sulfate, promote the migration of corneal epithelial cells during wound repair.
Maltseva I; Chan M; Kalus I; Dierks T; Rosen SD
PLoS One; 2013; 8(8):e69642. PubMed ID: 23950901
[TBL] [Abstract][Full Text] [Related]
23. CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis.
Wang L; Yang H; Zang C; Dong Y; Shang J; Chen J; Wang Y; Liu H; Zhang Z; Xu H; Bao X; Zhang D
Neurobiol Dis; 2020 Feb; 134():104630. PubMed ID: 31678404
[TBL] [Abstract][Full Text] [Related]
24. Conditional Deletion of the L-Type Calcium Channel Cav1.2 in NG2-Positive Cells Impairs Remyelination in Mice.
Santiago González DA; Cheli VT; Zamora NN; Lama TN; Spreuer V; Murphy GG; Paez PM
J Neurosci; 2017 Oct; 37(42):10038-10051. PubMed ID: 28899915
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinases shape the oligodendrocyte (niche) during development and upon demyelination.
Gorter RP; Baron W
Neurosci Lett; 2020 Jun; 729():134980. PubMed ID: 32315713
[TBL] [Abstract][Full Text] [Related]
26. Inhibiting Bone Morphogenetic Protein 4 Type I Receptor Signaling Promotes Remyelination by Potentiating Oligodendrocyte Differentiation.
Govier-Cole AE; Wood RJ; Fletcher JL; Gonsalvez DG; Merlo D; Cate HS; Murray SS; Xiao J
eNeuro; 2019; 6(2):. PubMed ID: 31028086
[TBL] [Abstract][Full Text] [Related]
27. Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination.
Coppolino GT; Marangon D; Negri C; Menichetti G; Fumagalli M; Gelosa P; Dimou L; Furlan R; Lecca D; Abbracchio MP
Glia; 2018 May; 66(5):1118-1130. PubMed ID: 29424466
[TBL] [Abstract][Full Text] [Related]
28. Intranasal Administration of Undifferentiated Oligodendrocyte Lineage Cells as a Potential Approach to Deliver Oligodendrocyte Precursor Cells into Brain.
Gómez-Pinedo U; Matías-Guiu JA; Benito-Martín MS; Moreno-Jiménez L; Sanclemente-Alamán I; Selma-Calvo B; Pérez-Suarez S; Sancho-Bielsa F; Canales-Aguirre A; Mateos-Díaz JC; Hernández-Sapiéns MA; Reza-Zaldívar EE; Ojeda-Hernández DD; Vidorreta-Ballesteros L; Montero-Escribano P; Matías-Guiu J
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639079
[TBL] [Abstract][Full Text] [Related]
29. A modified flavonoid accelerates oligodendrocyte maturation and functional remyelination.
Su W; Matsumoto S; Banine F; Srivastava T; Dean J; Foster S; Pham P; Hammond B; Peters A; Girish KS; Rangappa KS; Basappa ; Jose J; Hennebold JD; Murphy MJ; Bennett-Toomey J; Back SA; Sherman LS
Glia; 2020 Feb; 68(2):263-279. PubMed ID: 31490574
[TBL] [Abstract][Full Text] [Related]
30. Efficient Remyelination Requires DNA Methylation.
Moyon S; Ma D; Huynh JL; Coutts DJC; Zhao C; Casaccia P; Franklin RJM
eNeuro; 2017; 4(2):. PubMed ID: 28451635
[TBL] [Abstract][Full Text] [Related]
31. Lack of astrocytes hinders parenchymal oligodendrocyte precursor cells from reaching a myelinating state in osmolyte-induced demyelination.
Lohrberg M; Winkler A; Franz J; van der Meer F; Ruhwedel T; Sirmpilatze N; Dadarwal R; Handwerker R; Esser D; Wiegand K; Hagel C; Gocht A; König FB; Boretius S; Möbius W; Stadelmann C; Barrantes-Freer A
Acta Neuropathol Commun; 2020 Dec; 8(1):224. PubMed ID: 33357244
[TBL] [Abstract][Full Text] [Related]
32. TNFR2 Signaling Regulates the Immunomodulatory Function of Oligodendrocyte Precursor Cells.
Desu HL; Illiano P; Choi JS; Ascona MC; Gao H; Lee JK; Brambilla R
Cells; 2021 Jul; 10(7):. PubMed ID: 34359956
[TBL] [Abstract][Full Text] [Related]
33. Myelin regulatory factor drives remyelination in multiple sclerosis.
Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
[TBL] [Abstract][Full Text] [Related]
34. The K
Albrecht S; Korr S; Nowack L; Narayanan V; Starost L; Stortz F; Araúzo-Bravo MJ; Meuth SG; Kuhlmann T; Hundehege P
Glia; 2019 May; 67(5):870-883. PubMed ID: 30623969
[TBL] [Abstract][Full Text] [Related]
35. Nucleoporin Seh1 Interacts with Olig2/Brd7 to Promote Oligodendrocyte Differentiation and Myelination.
Liu Z; Yan M; Liang Y; Liu M; Zhang K; Shao D; Jiang R; Li L; Wang C; Nussenzveig DR; Zhang K; Chen S; Zhong C; Mo W; Fontoura BMA; Zhang L
Neuron; 2019 May; 102(3):587-601.e7. PubMed ID: 30876848
[TBL] [Abstract][Full Text] [Related]
36. CXCR2 Signaling and Remyelination in Preclinical Models of Demyelination.
Skinner DD; Lane TE
DNA Cell Biol; 2020 Jan; 39(1):3-7. PubMed ID: 31851535
[TBL] [Abstract][Full Text] [Related]
37. Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination.
Lau LW; Keough MB; Haylock-Jacobs S; Cua R; Döring A; Sloka S; Stirling DP; Rivest S; Yong VW
Ann Neurol; 2012 Sep; 72(3):419-32. PubMed ID: 23034914
[TBL] [Abstract][Full Text] [Related]
38. The Divalent Metal Transporter 1 (DMT1) Is Required for Iron Uptake and Normal Development of Oligodendrocyte Progenitor Cells.
Cheli VT; Santiago González DA; Marziali LN; Zamora NN; Guitart ME; Spreuer V; Pasquini JM; Paez PM
J Neurosci; 2018 Oct; 38(43):9142-9159. PubMed ID: 30190412
[TBL] [Abstract][Full Text] [Related]
39. Neuronal cholesterol synthesis is essential for repair of chronically demyelinated lesions in mice.
Berghoff SA; Spieth L; Sun T; Hosang L; Depp C; Sasmita AO; Vasileva MH; Scholz P; Zhao Y; Krueger-Burg D; Wichert S; Brown ER; Michail K; Nave KA; Bonn S; Odoardi F; Rossner M; Ischebeck T; Edgar JM; Saher G
Cell Rep; 2021 Oct; 37(4):109889. PubMed ID: 34706227
[TBL] [Abstract][Full Text] [Related]
40. GD1a Overcomes Inhibition of Myelination by Fibronectin via Activation of Protein Kinase A: Implications for Multiple Sclerosis.
Qin J; Sikkema AH; van der Bij K; de Jonge JC; Klappe K; Nies V; Jonker JW; Kok JW; Hoekstra D; Baron W
J Neurosci; 2017 Oct; 37(41):9925-9938. PubMed ID: 28899916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
